GPT and fatty liver disease: It has been demonstrated that MT at doses of 40, 80, and 160 mg/kg/day for 28 days mitigated high-fructose diet (HFD)-induced hepatic steatosis, and reduced the expression of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), while reducing malondialdehyde and increasing reduced glutathione.